Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiemetic study methodology: recommendations for future studies

I N Olver1

  • 1Medical Oncology, Royal Adelaide Hospital, S.A., Australia.

Oncology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study.

Internal medicine journal·2014
Same author

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2013
Same author

Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Phase II study of acivicin in patients with recurrent high grade astrocytoma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2008
Same author

Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma.

European journal of cancer (Oxford, England : 1990)·2007
Same author

Why we will need to learn new skills to control cancer.

Internal medicine journal·2007
Same journal

SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

Oncology·2026
Same journal

Letter to the Editor.

Oncology·2026
Same journal

FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Oncology·2026
Same journal

Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

Oncology·2026
Same journal

Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

Oncology·2026
Same journal

Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis.

Oncology·2026
See all related articles

Future antiemetic research will improve study designs by incorporating preclinical data and patient-reported outcomes. Early trials will optimize dosing and administration, while later studies will assess cost-effectiveness and target specific issues like delayed emesis.

Area of Science:

  • Pharmacology
  • Clinical Trial Design
  • Oncology Supportive Care

Background:

  • Current antiemetic studies face challenges requiring methodological improvements.
  • Advances in understanding emesis and antiemetic mechanisms are crucial for better clinical trial design.

Purpose of the Study:

  • To outline a refined methodology for future antiemetic clinical studies.
  • To enhance the design and execution of antiemetic research for improved patient outcomes.

Main Methods:

  • Future studies will integrate preclinical findings into rational clinical designs.
  • Phase I and II trials will focus on determining minimum effective doses, optimal administration routes, and schedules.
  • Phase III trials will incorporate novel endpoints like cost-effectiveness and investigate prognostic factors.

Related Experiment Videos

Main Results:

  • Methodological advancements are proposed to address current study limitations.
  • Early phase trials will establish optimal dosing and administration parameters.
  • Later phase trials will evaluate cost-effectiveness and target specific challenges such as delayed emesis.

Conclusions:

  • Future antiemetic studies require a more rational, evidence-based approach.
  • Optimizing antiemetic regimens through early and late phase trials is essential.
  • Patient evaluation of overall benefit should be a key component of future antiemetic research.